ICM
JSPRW icon

Ionic Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Ionic Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-417,132
Closed -$20.9K – 221
2023
Q3 		$20.9K Sell
417,132
-26,079
-6% -$2.24K 0.01% 190
2023
Q2 		$62.2K Buy
443,211
+185,268
+72% +$28.5K 0.02% 164
2023
Q1 		$51.6K Sell
257,943
-201,448
-44% -$29.4K 0.02% 215
2022
Q4 		$13.8K Hold
459,391
– – ﹤0.01% 305
2022
Q3 		$36K Buy
459,391
+93,746
+26% +$8.18K ﹤0.01% 369
2022
Q2 		$33K Hold
365,645
– – ﹤0.01% 380
2022
Q1 		$121K Buy
365,645
+26,969
+8% +$15K 0.01% 345
2021
Q4 		$498K Buy
+338,676
New +$472K 0.06% 220

Other funds holding JSPRW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $2.12B AUM 1.81% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return